Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FYBZM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,335
Award facts
- Contract value 100% obligated
- $9,334.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,334.98 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packages) on October 27, 2025, with completion targeted for October 28, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX). The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations.
This delivery order represents a routine pharmaceutical procurement within AmerisourceBergen's $999,999,999.00 prime IDC with DLA, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military and federal healthcare systems. RINVOQ (upadacitinib) is a prescription immunosuppressant used in the treatment of rheumatoid arthritis and other inflammatory conditions, consistent with AmerisourceBergen's extensive portfolio of specialty medications and brand-name pharmaceuticals supplied to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs. The competitively awarded contract reflects AmerisourceBergen's established capability to fulfill federal medical procurement requirements for both routine and specialized pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DB26FYBZM?
SPE2DB26FYBZM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FYBZM worth?
The government has obligated $9,335 on SPE2DB26FYBZM.
Is contract SPE2DB26FYBZM an order under another contract?
Yes. SPE2DB26FYBZM is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB26FYBZM competed?
The extent of competition for SPE2DB26FYBZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award